A Big Week for Psychedelic Stocks: 2 CEOs Step Down, MDMA Patents and a Phase 3 Trial
Compass Pathways and Small Pharma announce executive shakeup, Mydecine and Awakn push forward with new research
Day: July 22, 2022
Company Spotlight: NaturoMed Therapeutics
Canadian organic mushroom company NaturoMed Therapeutics looks to produce psilocybin in Q4 2022
End of content
End of content